Meditor Pharmaceuticals Ltd. – Product Pipeline Review – Q1 2011 by GlobalMarketsDirect

VIEWS: 1 PAGES: 21

More Info
									         Meditor Pharmaceuticals Ltd. – Product Pipeline
                      Review – Q1 2011
                                                                                          Reference Code: GMDHC0284CDB

                                                                                                Publication Date: MAR 2011




Meditor Pharmaceuticals Ltd. – Product Pipeline Review – Q1 2011                            GMDHC0284CDB / Published MAR 2011

© Global Markets Direct. This report is a licensed product and is not to be photocopied                                Page(1)
Meditor Pharmaceuticals Ltd. – Product Pipeline Review




Ta b le o f Co n te n ts
Table of Contents                                                                                                                         2
List of Tables                                                                                                                            3
List of Figures                                                                                                                           3
Meditor Pharmaceuticals Ltd. Snapshot                                                                                                     4
    Meditor Pharmaceuticals Ltd. Overview                                                                                                 4
    Key Information                                                                                                                       4
    Key Facts                                                                                                                             4
Meditor Pharmaceuticals Ltd. – Research and Development Overview                                                                          5
    Key Therapeutic Areas                                                                                                                 5
Meditor Pharmaceuticals Ltd. – Pipeline Review                                                                                            7
    Pipeline Products by Stage of Development                                                                                             7
    Pipeline Products – Monotherapy                                                                                                       8
Meditor Pharmaceuticals Ltd. – Pipeline Products Glance                                                                                   9
    Meditor Pharmaceuticals Ltd. Clinical Stage Pipeline Products                                                                         9
         Phase II Products/Combination Treatment Modalities                                                                               9
Meditor Pharmaceuticals Ltd. – Drug Profiles                                                                                             10
    MTR-106                                                                                                                              10
         Product Description                                                                                                             10
         Mechanism of Action                                                                                                             10
         R&D Progress                                                                                                                    10
    MTR105                                                                                                                               11
         Product Description                                                                                                             11
         Mechanism of Action                                                                                                             11
         R&D Progress                                                                                                                    11
    MTR107                                                                                                                               12
         Product Description                                                                                                             12
         Mechanism of Action                                                                                                             12
         R&D Progress                                                                                                                    12
Meditor Pharmaceuticals Ltd. – Pipeline Analysis                                                                                         14
    Meditor Pharmaceuticals Ltd. – Pipeline Products by Therapeutic Class                                                                14
    Meditor Pharmaceuticals Ltd. – Pipeline Products by Route of Administration                                                          15
Meditor Pharmaceuticals Ltd. – Locations And Subsidiaries                                                                                16
    Head Office                                                                                                                          16
    Other Locations & Subsidiaries                                                                                                       16
Recent Developments                                                                                                                      17
         Jun 12, 2008: Meditor Pharmaceuticals Ltd Reports Positive Results from Phase II Migraine Trial                                 17
         Jun 11, 2008: MTR106 Tablets Were Found To Be Effective In Acute Migraine Attacks                                               17
         Nov 06, 2007: A Phase II, Randomized, Double Blind, Placebo-Controlled Dose-Escalating Study, Meets The Clinical Endpoints Of
         MTR106 Tablets During the Treatment Of Acute Migraine Attacks Without Aura In Females                                           18
         Oct 04, 2006: Meditor Pharmaceuticals Provides Updates On Phase II Eastern European Clinical Study To Assess The Pharmacokinetics
         and Pharmacodynamics Of Orally Administered MTR106                                                                              18
         Sep 27, 2006: Meditor Pharmaceuticals Provides Update on Phase II Trial Assessing the Pharmacokinetic and Pharmacodynamic Effects
         of Intravenously Administered MTR107 in ESRD Patients                                                                           18
Appendix                                                                                                                                 20
    Methodology                                                                                                                          20
         Coverage                                                                                                                        20
         Secondary Research                                                                                                              20




Meditor Pharmaceuticals Ltd. – Product Pipeline Review – Q1 2011                                           GMDHC0284CDB / Published MAR 2011

©Global Markets Direct.. This report is a licensed product and is not to be photocopied                                                  Page(2)
Meditor Pharmaceuticals Ltd. – Product Pipeline Review



         Primary Research                                                                                                                                                            20
         Expert Panel Validation                                                                                                                                                     21
    Contact Us                                          
								
To top